Valeant Pharmaceuticals Intl Company Profile (TSE:VRX)

Analyst Ratings

Consensus Ratings for Valeant Pharmaceuticals Intl (TSE:VRX) (?)
Ratings Breakdown: 4 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.20)
Consensus Price Target: C$107.00

Analysts' Ratings History for Valeant Pharmaceuticals Intl (TSE:VRX)
Show:
DateFirmActionRatingPrice TargetActions
7/20/2016TD SecuritiesReiterated RatingHoldC$38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/12/2016Royal Bank Of CanadaReiterated RatingSector PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2016ScotiabankReiterated RatingSector PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/19/2015Citigroup Inc.Reiterated RatingOverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/2/2015Goldman Sachs Group Inc.DowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/24/2014 forward)

Earnings

Earnings History for Valeant Pharmaceuticals Intl (TSE:VRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/9/2016        
5/9/2014$1.83$1.90ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/20132Q13$0.03ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Valeant Pharmaceuticals Intl (TSE:VRX)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Valeant Pharmaceuticals Intl (TSE:VRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Valeant Pharmaceuticals Intl (TSE:VRX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
11/5/2015J. Michael PearsonDirectorSell350,000C$0.00C$0.00Tweet This Trade  Share This Trade on StockTwits
10/21/2015Ron FarmerDirectorBuy1,000C$193.00C$193,000.00Tweet This Trade  Share This Trade on StockTwits
5/26/2015Whitaker AnneInsiderBuy2,500C$234.00C$585,000.00Tweet This Trade  Share This Trade on StockTwits
5/4/2015Robert Roswell Chai-OnnInsiderSell90,938C$222.54C$20,237,433.46Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Valeant Pharmaceuticals Intl (TSE:VRX)
DateHeadline
07/23/16 10:29 AMValeant Pharmaceuticals International, Inc. (NYSE:VRX): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/22/16 07:00 PMStock Gapping Down Pre-market: Valeant Pharmaceuticals International, Inc. (NYSE:VRX) - TGP
07/22/16 07:00 PMBiotech Daily Digest: Valeant Pharmaceuticals Intl Inc (VRX) and Relypsa Inc (RLYP) - Smarter Analyst
07/20/16 10:02 AMValeant and Progenics Announce FDA Approves RELISTOR® Tablets for the ...
07/20/16 10:02 AMValeant/Progenics Relistor Ok'd; FDA Panel Backs Brodalumab
07/20/16 10:02 AMValeant Pharmaceuticals Intl Inc (NYSE:VRX): Analyst Believes Trends Have Not Been Positive
07/19/16 07:21 PMCanaccord Shares Thoughts on Valeant Pharmaceuticals Intl Inc (VRX) as FDA Holds Advisory Committee for ... - Smarter Analyst
07/19/16 08:06 AMHC Stocks Assessment: Pfizer Inc. (NYSE:PFE), Valeant Pharmaceuticals Intl Inc (NYSE:VRX) - share market updates (press release)
07/19/16 08:06 AMHC Stocks Movements: Mast Therapeutics Inc (NYSEMKT:MSTX), Valeant Pharmaceuticals Intl Inc (NYSE:VRX) - share market updates (press release)
07/19/16 08:06 AMRodman & Renshaw Analyst Remains Bullish on Valeant Pharmaceuticals Intl Inc (VRX) Ahead of FDA Advisory ... - Smarter Analyst
07/16/16 10:21 AMValeant Pharmaceuticals Comments On Recent Stock Transactions
07/16/16 10:21 AMValeant Pharmaceuticals Intl Inc (VRX): Bill Ackman's Take on Left's New Short
07/16/16 10:21 AMValeant Pharmaceuticals Intl Inc: Has VRX Stock Finally Bottomed?
07/15/16 06:11 PMValeant Pharmaceuticals International (NYSE:VRX) Remains An Important Shareholder With Over 3.5M Shares- Arena ... - Seneca Globe
07/15/16 06:11 PMValeant Pharmaceuticals Intl Inc's (VRX) Brodalumab May Face Restrictions As FDA Findings Suggest Higher Suicide ... - TCC
07/15/16 06:11 PMValeant Pharmaceuticals Intl Inc: Why Long-Term Investors are Pulling Out? - Bidness ETC
07/15/16 06:11 PMValeant Pharmaceuticals Intl Inc (VRX): Bill Ackman's Take on Left's New Short - TCC
07/15/16 12:31 PMValeant Pharmaceuticals Announces Second Quarter Results Conference Call Date And Details
07/15/16 12:31 PMValeant Pharmaceuticals Intl Inc's (VRX) Brodalumab May Face Restrictions As FDA Findings Suggest Higher Suicide Rate
07/15/16 12:31 PMValeant Pharmaceuticals: Priced For Disaster
07/15/16 10:29 AMAckman Again Whipsawed by Herbalife, Valeant as Regulators Disappoint Pershing -
07/15/16 09:25 AM2 Forgotten Activists In Herbalife: David Einhorn And Dan Loeb -
07/15/16 08:44 AMValeant (VRX) Stock Falls on FDA Scrutiny -
07/15/16 08:30 AMValeant psoriasis drug's suicide risk hard to assess -FDA Staff - [Reuters - UK Focus] - Valeant Pharmaceuticals International (NYSE: VRX - news) Inc's experimental drug to treat the skin disorder psoriasis carries a potential risk of suicide that is challenging to assess due to limited data, according to a preliminary review by the U.S (Other OTC: UBGXF - news) . The review comes two days ahead of a meeting of outside experts who will advise the FDA on whether the drug should be approved. In clinical trials of the drug, brodalumab, there were six suicides across all programs: four in psoriasis studies, one in a rheumatoid arthritis study and one in a psoriatic arthritis study.
07/14/16 07:25 PMHC Stocks Alerts: Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Emergent Biosolutions Inc (NYSE:EBS) - share market updates (press release)
07/14/16 07:25 PMValeant Pharmaceuticals Intl Inc (VRX) Risk Outweighs the Positive Catalysts Ahead: Wells Fargo - TCC
07/14/16 07:25 PMValeant Pharmaceuticals Intl Inc's Hard Times Mean Avoid VRX Stock - Investorplace.com
07/14/16 10:49 AMValeant Pharmaceuticals Intl Inc(NYSE:VRX): Should Investors Short The Stock? - TCC
07/13/16 07:30 PMValeant Pharmaceuticals Intl Inc (VRX) Options Pop After Citron Swipe - Schaeffers Research (blog)
07/13/16 10:01 AMValeant Pharmaceuticals Intl : Sequoia Fund exits Valeant position after losses
07/13/16 10:01 AMSequoia Fund sells Valeant stake
07/12/16 07:25 PMValeant Pharmaceuticals Intl Inc (VRX) Script Performance To Remain Relatively Flat: RBC Capital
07/12/16 05:42 PMLong-Time Valeant Investor Sequoia Fund Exits After Losses -
07/12/16 11:25 AMValeant Pharmaceuticals International Inc Stock Momentum at Critical Inflection Point - CML News
07/12/16 11:25 AMHC Stocks News Ring: Valeant Pharmaceuticals Intl Inc (VRX), Juno Therapeutics Inc (JUNO) - share market updates (press release)
07/12/16 11:25 AMHC Stocks Zone: Lannett Company, Inc. (NYSE:LCI), Valeant Pharmaceuticals Intl Inc (NYSE:VRX) - share market updates (press release)
07/11/16 07:00 PMValeant Pharmaceuticals International, Inc. (NYSE:VRX) Quarterly Accounts Payable At $438.1 Millions - RealistInvestor.com
07/11/16 07:00 PMValeant Pharmaceuticals Intl Inc (VRX) Script Performance To Remain Relatively Flat: RBC Capital - TCC
07/11/16 07:00 PMValeant Pharmaceuticals Intl Inc (NYSE:VRX) & Mitel Networks Corporation (NASDAQ:MITL) Stocks on the Run - Money News (press release)
07/10/16 06:13 PMValeant Pharmaceuticals International, Inc. (NYSE:VRX) Broker Price Targets For The Coming Week - Fiscal Standard
07/09/16 10:04 AMIs Valeant Pharmaceuticals Intl Inc (VRX) No Less than Walking Dead? - TCC
07/08/16 09:59 AMAnalyst's Checklist Stocks: Valeant Pharmaceuticals International, Inc. (NYSE:VRX) , UnitedHealth Group Incorporated ... - Street Updates
07/07/16 07:15 PMValeant Pharmaceuticals Intl Inc (NYSE:VRX): Second Published Phase 3 Trial Demonstrates Greater Efficacy - TCC
07/07/16 09:52 AMValeant - Baby Steps Back To Prosperity - Seeking Alpha
07/06/16 07:40 PMValeant Pharmaceuticals Intl Inc (VRX) Calls Hot After Drug, Walgreens News - Schaeffers Research (blog)
07/06/16 06:04 AMRite Aid Corporation (NYSE:RAD) & Valeant Pharmaceuticals Intl (NYSE:VRX) Stocks Alert - Money News (press release)
07/06/16 06:04 AMValeant Pharmaceuticals Intl Inc (VRX) May Have A Buyer For Derma Assets; Finally Some Good News? - Bidness ETC
07/05/16 06:46 PMOpinion: Time to short Valeant bonds, go long its stock
07/05/16 06:46 PMBrexit Fallout: Outlooks Diverge on Valeant (VRX)
07/03/16 05:49 AMValeant Pharmaceuticals Int Inc (VRX) Sees a Rare Surge In Put Volume - Schaeffers Research (blog)

Social

About Valeant Pharmaceuticals Intl

Valeant Pharmaceuticals Intl logoValeant Pharmaceuticals International, Inc. is a specialty pharmaceutical and medical device company. The Company is engaged in developing, manufacturing, and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices), which are marketed directly or indirectly in over 100 countries. The Company operates through two segments: developed markets and emerging markets. The Company's developed markets segment consists of sales in the United States of pharmaceutical products, OTC products, and medical device products. The Company's Emerging Markets segment consists of branded generic pharmaceutical products and branded pharmaceuticals, OTC products, and medical device products.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: TSE
  • Symbol: VRX
  • CUSIP:
Key Metrics:
  • Previous Close: $32.03
  • 50 Day Moving Average: $29.64
  • 200 Day Moving Average: $64.48
  • P/E Ratio: N/A
  • P/E Growth: 0.25
  • Market Cap: $10.30B
  • Current Year EPS Consensus Estimate: $6.61 EPS
  • Next Year EPS Consensus Estimate: $N/A EPS
Additional Links:
Valeant Pharmaceuticals Intl (TSE:VRX) Chart for Sunday, July, 24, 2016